Stay updated on Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.

Latest updates to the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.5.0 added. Revision: v3.4.3 deleted.SummaryDifference0.1%

- Check48 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.4.2 was added; the lapse in government funding notice and the v3.4.1 revision were removed.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a site-wide Notice about a lapse in government funding and updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a Show glossary option and updated QC-related labels and policy text (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0). Removed the older wording variants (Last Update Submitted that met QC Criteria; No FEAR Act data) and the previous revision label (Revision: v3.3.4).SummaryDifference0.2%

Stay in the know with updates to Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.